Amicus Therapeutics, Inc. (NASDAQ:FOLD) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 24.6% in the past one-month time frame.
The company has seen one upward estimate revision in the past 30 days. However, the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future
Amicus Therapeuticshas a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Amicus Therapeutics, Inc. Price
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Amicus Therapeutics, Inc. (FOLD): Free Stock Analysis Report
Original post
Zacks Investment Research